Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon

Carcinogenesis

Volumn 21, Issue 9, 2000, Pages 1655-1660

  Yang, Kan ^a   Lamprecht, Sergio A ^a   Liu, Yanhui ^a   Shinozaki, Hiroharu ^a   Fan, Kunhua ^a   Leung, Denis ^b   Newmark, Harold ^a   Steele, Vernon E ^c   Kelloff, Gary J ^c   Lipkin, Martin ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BROXURIDINE; CYCLIN D1; FLAVONOID; QUERCETIN; RUTOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL LABELING; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON MUCOSA; CONTROLLED STUDY; DIET SUPPLEMENTATION; EPITHELIUM CELL; EPITHELIUM DYSPLASIA; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033862118     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.9.1655     Document Type: Article

References (65)

1. The flavonoids: A class of semi-essential food components: Their role in human nutrition
2. Bioavailability and health effects of dietary flavonoids in man
3. Polyphenols: Chemistry, dietary sources, metabolism and nutritional significance
4. Hydrolysis of flavonoids by human intestinal bacteria
5. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia
6. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet
7. Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons
8. Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin
9. Inhibition of 7,12-dimethylbenz(α)anthracene-and N-nitrosomethylurea-induced rat mammary gland by dietary flavonol quercetin
10. Inhibition by quercetin of the promoting effect of teleocidin on skin papilloma formation in mice initiated with 7,12-dimethylbenz(α)anthracene
11. Quercetin down-regulates signal transduction in human breast carcinoma cells
12. The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin
13. Synergistic action of quercetin and genistein in human ovarian carcinoma cells
14. Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors
15. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells
16. Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells)
17. Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein in human colon cancer cells
18. Dietary factors in human colorectal cancer
19. The effect of starvation and refeeding on intestinal cell proliferation in the mouse
20. Comparison of circadian variation in cell proliferation in normal and colonic epithelial cells
21. Circadian variations of epithelial cell proliferation in human rectal crypts
22. Phase 1 and phase 2 proliferation lesions of colonic epithelial cells in diseases leading to colonic cancer
23. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells
24. 1 phase of the cell cycle
25. Quercetin inhibits p21-Ras expression in human colon cancer cell lines and in primary colorectal tumors
26. Cell cycle regulators: Mechanisms and their role in aetiology, prognosis and treatment of cancer
27. 1 cyclin dependent-kinases
28. Cyclins and cancer II. Cyclin D and CDK inhibitors come of age
29. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
30. 1 and E in human colon
31. Concurrent overexpression of cyclin D1 and cyclin-dependent protein kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients
32. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis
33. Extensive apoptotic death of rat colonic cells deprived of crypt habitat
34. Epithelial cell growth and differentiation. II. Intestinal Apoptosis
35. Quercetin inhibited DNA synthesis and induced apoptosis associated with increase in c-fos mRNA level and the upregulation of p21(WAFICIP1) mRNA and protein expression during liver regeneration after partial hepatectomy
36. Molecular mechanisms in the antiproliferative action of quercetin
37. Quercetin-induced apoptosis in colorectal cancer cells: Possible role of EGF receptor signaling
38. Induction of apoptosis by quercetin: Involvement of heat shock protein
39. Modulation of the heat-induced activation of mitogen-activated protein (MAP) kinase by quercetin
40. Differential distribution of protein kinases along the crypt-to-lumen regions of rat colonic epithelium
41. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases
42. Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily. Role as anticancer agents
43. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis
44. Effects of naturally occurring flavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs
45. 1 and pRb in human colon carcinomas
46. Mutagenic activity of quercetin and related compounds
47. Genetic toxological testing of some plant flavonoids by the micronucleus test
48. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum)
49. Carcinogenic examination of quercetin and rutin in ACI rats
50. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[α]-anthracene-induced mammary cancer in rats
51. Quercetin enhances pretumorous lesions in the NMU model of rat pancreatic carcinogenesis
52. Nutrition and dietary carcinogens
53. Plant phenolic compounds as inhibitors of mutagenesis and carcinogenesis
54. Plasma metabolites of quercetin and their antioxidant properties
55. 2)-induced NF-kB DNA binding activity and DNA damage in HepG2 cells
56. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals
57. Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion
58. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro
59. Optimization of nutrition: Polyphenols and vascular protection
60. Intake of flavonoids and lung cancer
61. Bioavailability of the dietary antioxidant flavonoid quercetin in man
62. Relative bioavailability of the antioxidant flavonoid from various foods in man
63. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
64. Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition